Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Upgrades Salesforce to Outperform with Increased Price Target

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
Technology Artificial intelligence Markets and money
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Analyst Rob Oliver from Baird has boosted Salesforce (NYSE:CRM) from a “neutral” to an “outperform” rating on February 29, 2024. He also raised the price target to $355 from $310. This upgrade is fueled by various positive factors such as price hikes, increased spending in the front office, and enhanced sales execution that could propel company growth. The analysts highlighted Salesforce’s impressive performance in 2023, especially in terms of delivering on margins, which influenced the decision to upgrade the stock. Following this announcement, Salesforce stock saw a 1.3% uptick.

CRM Stock Fluctuates on February 29th: Analysis and Insights

On February 29, 2024, CRM stock experienced some fluctuations in its performance. According to data from CNN Money, CRM was trading near the top of its 52-week range and above its 200-day simple moving average, indicating positive momentum for the stock. The price of CRM shares decreased by $0.89 since the market last closed, representing a 0.30% drop. The stock closed at $299.50, but it saw a rebound in after-hours trading, rising by $3.05. This mixed performance on February 29th may have been influenced by various factors such as market volatility, company news, or broader economic conditions. Despite the slight drop during regular trading hours, the after-hours increase suggests that investors may have regained confidence in CRM’s prospects. It is important for investors to closely monitor stock movements and consider all available information before making any investment decisions. CRM’s performance on February 29th serves as a reminder of the volatility of the stock market and the importance of staying informed to make well-informed investment choices.

Salesforce (CRM) Stock Performance: Mixed Results for Financial Year 2023 and Q3 2024

Salesforce (CRM) stock experienced a mixed performance on February 29, 2024, as the company reported its financial results for the past year and the third quarter. According to data from CNN Money, Salesforce’s total revenue for the past year was $31.35 billion, which represented an 18.35% increase compared to the previous year. However, the total revenue remained flat since the last quarter, standing at $8.72 billion.

The net income for Salesforce was $208.00 million for the past year, a significant decrease of 85.6% compared to the previous year. The net income for the third quarter was $1.22 billion, which also decreased by 3.39% since the last quarter. Similarly, the earnings per share (EPS) for Salesforce were $0.21 for the past year, marking an 85.93% decrease from the previous year. The EPS for the third quarter was $1.25, remaining flat since the last quarter.

The mixed financial results for Salesforce had an impact on its stock performance on February 29, 2024. Investors may have been concerned about the significant decrease in net income and EPS compared to the previous year. However, the increase in total revenue for the past year could indicate growth potential for the company in the future.

Tags: CRM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Xometry Projects Strong Start and Growth for 2024

Finance_ blue chart

Barclays Analyst Adjusts Price Target for Oceaneering International

Healthcare cloud based

GH Research Reports Significant Net Loss in Second Quarter of 2023

Recommended

Hims & Hers Stock

Regulatory Storm Hits Hims & Hers as FDA Targets Marketing Claims

3 days ago
Berkshire Hathaway Stock

A New Era Dawns as Buffett Announces Berkshire Hathaway Exit

3 weeks ago
DouYu International Holdings Stock

DouYu’s Profit Turnaround Fails to Impress Skeptical Market

1 week ago
Desert Gold Ventures Stock

Desert Gold Ventures Stock: Mali Gold Project Sparks Investor Optimism

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Salesforce Leadership’s Stock Sales Raise Investor Concerns

Viking Therapeutics Approaches Critical Market Inflection Point

Uranium Energy Faces Investor Scrutiny Following Critical Short Report

Intel’s Nvidia Partnership Sparks Market Uncertainty

Immunocore Shares Face Technical Pressure Despite Solid Fundamentals

Opendoor Announces Sudden Departure of Finance Chief Amid Leadership Reshuffle

Trending

OFS Credit Stock
Analysis

OFS Credit Faces Market Pressure Following Quarterly Earnings Miss

by Andreas Sommer
September 22, 2025
0

Shares of OFS Credit came under significant selling pressure as the market reacted to disappointing third-quarter 2025...

Invesco S&P 500® Quality ETF Stock

Navigating Market Volatility with the Invesco S&P 500 Quality ETF

September 22, 2025
Microsoft Stock

Microsoft Navigates AI Expansion Amid Immigration Policy Shift

September 22, 2025
Salesforce Stock

Salesforce Leadership’s Stock Sales Raise Investor Concerns

September 22, 2025
Viking Therapeutics Stock

Viking Therapeutics Approaches Critical Market Inflection Point

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • OFS Credit Faces Market Pressure Following Quarterly Earnings Miss
  • Navigating Market Volatility with the Invesco S&P 500 Quality ETF
  • Microsoft Navigates AI Expansion Amid Immigration Policy Shift

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com